Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A mathematical model to investigate the transmission of COVID-19 in the Kingdom of Saudi Arabia

View ORCID ProfileFehaid Salem Alshammari
doi: https://doi.org/10.1101/2020.05.02.20088617
Fehaid Salem Alshammari
1Assistant professor in the deptarment of mathematics and statistics Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fehaid Salem Alshammari
  • For correspondence: falshammari{at}imamu.edu.sa
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Since the first confirmed case of SARS-CoV-2 coronavirus (COVID-19) in the 2nd day of March, Saudi Arabia has not report a quite rapid COVD-19 spread compared to America and many European countries. Possible causes include the spread of asymptomatic cases. To characterize the transmission of COVID-19 in Saudi Arabia, this paper applies a susceptible, exposed, symptomatic, asymptomatic, hospitalized, and recovered dynamical model, along with the official COVID-19 reported data by the Ministry of Health in Saudi Arabia. The basic reproduction number R0 is estimated to range from 2.87 to 4.9.

1 Introduction

As of April 22, 2020, more than 12772 cases and 114 deaths of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus had been confirmed in Saudi Arabia. Since the 4th of March [17], control measures have been implemented within Saudi Arabia to try to control the spread of the disease. Isolation of confirmed cases and contact tracing are crucial part of these measures, which are common interventions for controlling infectious disease outbreaks [26–28]. For example, the severe acute respiratory syndrome (SARS) outbreak SARS and Middle East respiratory syndrome (MERS), were controlled through tracing suspected cases and isolating confirmed cases because the majority of transmission occurred concurrent or after symptom onset [27–29].

However, it is unknown if transmission of COVID-19 can occur before symptom onset, which could decrease the effectiveness of isolation and contact tracing [26, 27, 29].

In this paper, the impact of asymptomatic COVID-19 cases on the spread of the disease will be considered using a modified version of the susceptible-exposed-infected-recovered (SEIR) dynamical model, along with the official COVID-19 data reported by the ministry of health in Saudi Arabia. Other main objectives of this paper include: estimating the basic reproduction number (R0) of COVID-19 in Saudi Arabia and how interacting with infected individual (symptomatic and asymptomatic) affect the estimated number, estimating the maximum required number of hospital beds and intensive care units (ICU).

2 Model establishment

The population will be divided into six categories: susceptible (S), exposed (E), symptomatic (Y), asymptomatic (N), hospitalized (H), and recovered (R) individuals (SEYNHR). Individuals moves from the susceptible compartment S to the exposed compartment E after interacting with infected individuals with transmission rates β1, β2, and β3 as shown in Figure 1. COVID-19 is known to have an incubation period, from 2 to 14 days, between exposure and development of symptoms [6,30]. After this period, exposed individual transits from the compartment E to either compartment Y at a rate α, or to compartment N at a rate α(1 − γ). An individual could move from compartment N to Y at a rate K if they show symptoms. Once an individual becomes infected with the coronavirus that causes COVID-19, that individual develops immunity against the virus with a rate ΦY or the individual will be hospitalized with a rate of ϵ or die because of the disease with a rate of μ1. When individual becomes hospitalized, that individual receives treatment and develops immunity against the virus with a rate r or die because of the disease with a rate of μ2.

Figure 1:
  • Download figure
  • Open in new tab
Figure 1:

Schematic diagram of SEIHR compartment model. The arrows, except the black ones, represent progression from one compartment to the next.

As shown in Figure 1, the SEYNHR model has six compartments, and there fore a discrete dynamical system consisting six non-linear differential equations will be formed as the following: Embedded Image where N(t) = S(t) + E(t) + Y(t) + N(t) + H(t) + R(t). The next-generation matrix will be used to derive an analytical expression for the basic reproduction number (R0), for the compartmental model above. Calculating R0 is a useful metric for assessing the transmission potential of an emerging COVID19 in Saudi Arabia.

3 Basic reproduction number R0

An important concept in epidemiology is the basic reproduction number, defined as “the expected number of secondary cases produced, in a completely susceptible population, by a typical infective individual” [10]. The next generation method will be used to calculate R0 [11]. The system in Equation 1 can be rewritten as follows Embedded Image where F: = (F1, F2, F3, F4, F5, F6)T and V: = (V1, V2, V3, V4, V5, V6)T, or more explicitly

Embedded Image

The Jacobian matrices of F and V evaluated at the disease-free equilibrium (DFE) of the system in Equation 1, Embedded Image, are given by Embedded Image and

Embedded Image

Direct calculations show that Embedded Image where

Embedded Image

Denoting the 4×4 identity matrix by Embedded Image, the characteristic polynomial Γ(λ) of the matrix FV−1 is given by Embedded Image where

Embedded Image

The solutions λ1,2,3,4 are given by

Embedded Image

Therefore, the reproduction number for the SEYNHR model in Equation 1 is given by

Embedded Image

4 Results

At the initial time t = 0, if we set the initial population N(0) = 1, then N(0) = S(0)+E(0)+Y(0)+N(0)+H(0)+R(0) = 1. The transition probabilities between states are all in the range of [0, 1], i.e.,

Embedded Image

I fitted the model in Equation 1 to the published data from the Ministry of Health in Saudi Arabia (MOH) from 2nd day of March until the 14th of April to estimate values for the unknown parameters β1, β2, β3 and K using MATLAB. The results are shown in the upper panel of Figure 2. Increasing the value of K from 0.009/day requires increasing the value of β1, β2 and β3 from 0.267, 0.53 and 0.13 (day x individual)−1 to 0.5, 1 and 0.26 (day x individual)−1, respectively. All other parameters and their descriptions are given in Table 1. I assumed that the mean asymptomatic infectious period is the same as the mean symptomatic infectious period because there is no estimation available in the literature [9, 29]. Based on those estimated, assumed and measured values, the basic reproduction number R0 is estimated to range from 2.87 to 4.9. The variation of the basic reproduction number R0 for different values of β1, β2, ΦY, ΦN and K are shown in the heat maps in Figure 3. The upper heat map of Figure 3 shows that practicing physical distancing could significantly reduce the value of R0 and hence control the spread of the disease.

Figure 2:
  • Download figure
  • Open in new tab
Figure 2:

Numerical results of the SEYNHR model with the parameter listed on Table 1, where β1 = 0.35, β2 = 0.7, β3 = 0.18 and K = 0.009. The upper figure shows the estimated number of symptomatic COVID-19 cases, with the published data by the Ministry of Health in Saudi Arabia of confirmed COVID-19 cases (blue circles). The center figure shows the estimated susceptible, exposed, symptomatic, asymptomatic, hospitalized, and recovered sub-populations. The lower figure shows estimations of the hospitalized cases and the required ICU beds (black dashed line). The red line represents the number of hospital beds available, while the red dashed line represents the number of ICU beds available in Saudi Arabia.

Figure 3:
  • Download figure
  • Open in new tab
Figure 3:

Heat maps showing the variation of R0 for different parameter values: the upper heat map shows the variation of R0 for different values for β1 and β2, in the center the heat map shows the variation of R0 for different values for and ΦN and the lower heat map shows the variation of R0 for different values for β1 and K.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1:

Parameters used in the simulations.

The center panel of Figure 2 shows that about 18% of the entire Saudi population will be asymptomatic in the last week of May 2020 and about 17% will be exposed in the third week of May. The percentage of the entire population being symptomatic at anytime will not exceed 1%, which is estimated to occur in the third week of May. Moreover, about 60000 hospital beds and 18000 ICU beds are required (30% of the hospitalized cases [6]) immediately after the second week of May. Currently, the Ministry of Health designated 25 hospitals for COVID-19 infected patients with up to 80,000 beds and 8000 intensive care units (ICU) beds [25] and therefore extra 10000 ICU beds could be required.

5 Discussion

The parameter with the hight degree of uncertainty are the effective contact rates from symptomatic to susceptible β1, from asymptomatic to susceptible β2 and from hospitalized to susceptible β3 (expected to be a fraction of β1 because of the protective measures in hospitals), as well as the mean infectious periods for symptomatic Embedded Image and asymptomatic Embedded Image individuals. I estimated a maximum value of β1 to be 0.5 which is one half of the value reported by Li et al. [18]. This could be a reasonable estimation as we have not seen similar scenario in Saudi Arabia after 5 weeks since reaching 100 confirmed cases on the 14th of March (week 7 since the first case) as we have seen in many other countries like China, America and different European countries in the same timescale. This could be a result of the precautionary measures taken by the Saudi authorities, including closure of schools and universities that started as early as the 8th of March (six days after the first confirmed COVID-19 case in Saudi Arabia). Based on the above estimation for R0, the center panel of Figure 3 suggests that the infectious period for symptomatic patient could be in the range from 6.6 to 12.5 days (i.e., ΦY ∊ [0.08, 0.15]) and the infectious period for asymptomatic patient could be in the range from 6.6 to 25 days (i.e., ΦN ∊ [0.04,0.15]). The infectious period for symptomatic cases are consistent with what is being observed clinically [30].

In reality, R0 is not a biological constant; it could fluctuate daily depending on environmental and social factors such as percentage of entire susceptible population wearing suitable medical mask and practicing physical distancing. In the literature, estimates of R0 vary greatly: from 1 to 6 [18–24] up to 26.5 [9]. This variation is because of different assumptions and factors they had considered in the calculations. In general, considering asymptomatic infection sub-population will increase the estimated values of R0.

6 Conclusion

The contribution of undocumented COVID-19 infections (asymptomatic cases) on the transmission of the disease deserves further studies and investigations. This paper shows that asymptomatic cases of COVID-19 will drive the growth of the pandemic in Saudi Arabia. Therefore, more testing is needed to identify COVID-19 patients (symptomatic and asymptomatic) and to contain the spread of the disease.

Data Availability

The data used in my paper is the total number of confirmed cases of COVID-19 reported by the ministry of Health in Saudi Arabia from 2nd of March until the 21st of April 2020. Data supporting this paper are open and can be accessed through: Ministry of Health COVID 19 Dashboard. Saudi Arabia; 2020 [https://covid19.moh.gov.sa].

https://covid19.moh.gov.sa

References

  1. [1].
    Bernoulli D. “Essai d’une nouvelle analyse de la mortalit cause par la petite vrole.” Mm. Math Phys Acad Roy Sci Paris. 1:1–45 (1766).
    OpenUrl
  2. [2].
    Kermack, W. O., and McKendrick, A. G. “A Contribution to the Mathematical Theory of Epidemics.” Proc. Roy. Soc. Lond. A 115, 700–721 (1927).
    OpenUrlCrossRef
  3. [3].
    Bernoulli, D., Blower, S. “An attempt at a new analysis of the mortality caused by smallpox and of the advantages of inoculation to prevent it.” Reviews in Medical Virology, 14, 275–288 (2004).
    OpenUrlCrossRefPubMed
  4. [4].
    Jia Wangping, Han Ke, Song Yang, Cao Wenzhe, Wang Sheng-shu, Yang Shanshan, Wang Jianwei, Kou Fuyin, Tai Penggang, Li Jing, Liu Miao, He Yao. “Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan, China”. https://doi.org/10.1101/2020.03.18.20038570 (2020).
  5. [5].
    Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S. “The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak”. Science (New York, NY) (2020).
  6. [6].↵
    World Health Organization. Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Retrieved Mar. 14 (2020).
  7. [7].
    Hellewell J, Abbott S, Gimma A, Bosse N, Jarvis C., Russell T, Munday J, Kucharski A, Edmunds W. “Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.” Lancet Glob Health; 8: e488–96 (2004).
    OpenUrl
  8. [8].
    W. Guan, et al. “New England Journal of Medicine” (2020).
  9. [9].↵
    Aguilar A.B, Faust, J.S, Westafer L.M, Gutierrez, J.B. “Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission” https://doi.org/10.1101/2020.03.18.20037994 (2020).
  10. [10].↵
    Driessche P., James Watmough. “Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission”. Physica A 29–48 (2002).
  11. [11].↵
    Van den Driessche P., Watmough J., Mathematical biosciences 180, 29 (2002).
    OpenUrlCrossRefPubMedWeb of Science
  12. [12].
    General authority for statistics in Saudi Arabia, https://www.stats.gov.sa.
  13. [13].
    Lauer S. A., et al., Annals of Internal Medicine (2020).
  14. [14].
    Nishiura H., et al. “The rate of underascertainment of novel coronavirus (2019-ncov) infection: Estimation using japanese passengers data on evacuation flights” (2020).
  15. [15].
    Zhou F., et al. (2020).
  16. [16].
    Baud D., et al., The Lancet Infectious Diseases (2020).
  17. [17].↵
    Ministry of health in Saudi Arabia, https://www.moh.gov.sa.
  18. [18].↵
    Li R. et al. “Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)”. Science (2020).
  19. [19].
    Wu P. et al. “Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020”. Eurosurveillance 25 (2020).
  20. [20].
    Zhang S. et al. “Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis”. International Journal of Infectious Diseases (2020).
  21. [21].
    Li R. et al. “Clinical characteristics of 2019 novel coronavirus infection in China”. medRxiv (2020).
  22. [22].
    Wu JT, Leung K, Leung GM. “Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study”. The Lancet (2020).
  23. [23].
    Shen M, Peng Z, Xiao Y, Zhang L. “Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China”. bioRxiv doi: https://doi.org/10.1101/2020.01.23.916726 (2020).
  24. [24].↵
    Read JM., Bridgen JRE., Cummings DAT., Jewell CP. “Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions”. medRxiv. doi: https://doi.org/10.1101/2020.01.23.20018549 (2020).
  25. [25].↵
    World Health Organization, Regional Office for the Eastern Mediterranean. Available from: http://www.emro.who.int/media/news/who7saudi-arabia-join-forcesto-fight-covid-19-nationally-regionally-and-globally.html. [Last retrieved on 2020 Mar 31].
  26. [26].↵
    Fraser C, Riley S, Anderson RM, Ferguson NM. “Factors that make an infectious disease outbreak controllable”. Proc Natl Acad Sci USA; 101: 6146751 2004.
    OpenUrl
  27. [27].↵
    Peak CM, Childs LM, Grad YH, Buckee CO. “Comparing nonpharmaceutical interventions for containing emerging epidemics”. Proc Natl Acad Sci USA; 114: 4023728 (2017).
    OpenUrl
  28. [28].↵
    Kang M, Song T, Zhong H, et al. “Contact tracing for imported case of Middle East respiratory syndrome”. China (2015).
  29. [29].↵
    Hellewell J. et al. “Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts” The lancet (2020).
  30. [30].↵
    Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, et al. “Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia”. N Engl J Med (2020).
Back to top
PreviousNext
Posted May 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A mathematical model to investigate the transmission of COVID-19 in the Kingdom of Saudi Arabia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A mathematical model to investigate the transmission of COVID-19 in the Kingdom of Saudi Arabia
Fehaid Salem Alshammari
medRxiv 2020.05.02.20088617; doi: https://doi.org/10.1101/2020.05.02.20088617
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A mathematical model to investigate the transmission of COVID-19 in the Kingdom of Saudi Arabia
Fehaid Salem Alshammari
medRxiv 2020.05.02.20088617; doi: https://doi.org/10.1101/2020.05.02.20088617

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)